RECRUITING

Eccentric Muscle Training, Stimulation, and Biomarkers in SCI

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The investigators are studying a new rehabilitation treatment for individuals trying to recover walking after spinal cord injury (SCI). The investigators will test conditions in the blood and spinal fluid to determine the best time to start this new training program. This will include checking for certain features called biomarkers by testing participants' spinal fluid and blood and compare these features to individuals without SCI. These features will help investigators determine when to start the new training program, either right away or waiting for 3 months. The new training program uses walking downhill on a slight slope on a treadmill while muscles that are not working normally are stimulated to contract using low levels of electricity. Adding this stimulation will allow people to practice walking and other skills even though full muscle control has not recovered. This new program will be in addition to any other rehabilitation therapy and will not replace standard rehabilitation. The hope is to see if downhill training with muscle stimulation, when delivered at the most ideal time, will improve trunk and leg movement, walking, and overall function. This recovery of movement and function will be compared to people with SCI receiving standard rehabilitation alone. Certain regions of the brain and spinal cord will also be studied using MRI scans to determine if these are affected by the training and compare to individuals without SCI. The total length of the study for SCI participants will be up to 16 weeks if in the standard of care group and up to 33 weeks if in the trained group. Healthy control participants will be involved for 1-2 visits.

Official Title

Eccentric Motor Training With Neuromodulation and Biomarkers for Rehabilitation Readiness in Subacute SCI

Quick Facts

Study Start:2022-05-17
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05337982

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 85 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Discharged from inpatient rehabilitation;
  2. * AIS A-D at neurologic level C1-T10;
  3. * 18-85 years old.
  4. * Adults 18-85 years old;
  5. * no recent major musculoskeletal injury;
  6. * no recent surgery.
  1. * Use of botox in the past 3 months that reduces skeletal muscle function;
  2. * other neurologic conditions (i.e. brain injury, stroke, HIV);
  3. * current cancer diagnosis;
  4. * active deep vein thrombosis and anti-coagulation therapy;
  5. * skin wounds in regions that interfere with harness, stimulation pads or hand placement needed for training.
  6. * pregnancy;
  7. * ventilator-dependence;
  8. * cognitive conditions that preclude providing informed consent.
  9. * Implanted medical devices that are contraindicated for electrical stimulation or MRI \*(If SCI participants have conditions contraindicated for MRI they may still participate in the remainder of study activities without myelin status as an outcome measure. SCI is a rare condition therefore this is necessary in order to achieve the required sample size.)
  10. * Implanted medical devices that are contraindicated for MRI (MRI participants only);
  11. * neurologic conditions (i.e. brain injury, stroke, HIV);
  12. * current cancer diagnosis;
  13. * clotting disorders requiring anti-coagulation therapy;
  14. * inflammatory conditions like arthritis, ulcerative colitis, lupus, etc;
  15. * pregnancy;
  16. * fear of needles;
  17. * claustrophobia;
  18. * cognitive conditions that preclude providing informed consent.

Contacts and Locations

Study Contact

Lesley Fisher, BS
CONTACT
614-688-4589
lesley.fisher@osumc.edu
Michele Basso, EdD
CONTACT
614-292-0754
michele.basso@osumc.edu

Principal Investigator

D. Michele Basso, EdD
PRINCIPAL_INVESTIGATOR
Ohio State University

Study Locations (Sites)

The Ohio State University
Columbus, Ohio, 43210
United States

Collaborators and Investigators

Sponsor: Ohio State University

  • D. Michele Basso, EdD, PRINCIPAL_INVESTIGATOR, Ohio State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-05-17
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2022-05-17
Study Completion Date2025-12-31

Terms related to this study

Keywords Provided by Researchers

  • Spinal Cord Injury
  • SCI
  • Biomarkers
  • MRI
  • Locomotor Training
  • Downhill
  • Neuromodulation
  • Electrical Stimulation
  • CSF
  • Rehabilitation
  • Physical Therapy
  • Eccentric
  • Treadmill
  • blood draw

Additional Relevant MeSH Terms

  • Spinal Cord Injuries
  • Healthy